Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

FDA approves expanded use of Xenoview for lung imaging

FDA approves expanded use of 'powerful' lung imaging tool

The approval will make around 1 million more patients eligible to receive the specialized contrast, which enhances the evaluation of lung ventilation. 

soda soft drink coke

Drinking sugar ‘more problematic’ than eating it: Soda, fruit juice linked to high diabetes risk

“Rather than condemning all added sugars, future dietary guidelines might consider the differential effects of sugar based on its source and form," one researcher said.

Rishi Wadhera, MD, MPP, MPhil, associate director of the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School, Explains a report showing socioeconomic factors are driving increased cardiovascular death rates, especially in younger adults, and urges action to address these health disparities.

Death from heart disease more common in rural areas—what can cardiologists do?

Rishi Wadhera, MD, detailed new data that show how socioeconomic factors are driving cardiovascular death rates, especially in younger adults.

Robert F. Kennedy Jr RFK

RFK floats starting new medical journal for administration scientists

On a podcast with wellness guru Gary Brecka, HHS Secretary Robert F. Kennedy Jr. said major medical journals have succumbed to the corrupting influence of pharmaceutical companies, and he may ban scientists with the National Institutes of Health (NIH) from publishing in them.

Surgeons in Houston have performed the world’s first successful human implant of BiVACOR’s Total Artificial Heart (TAH) technology. The procedure was completed July 9, 2024, at The Texas Heart Institute at Baylor St. Luke’s Medical Center. It was part of an early feasibility study (EFS) first approved by the U.S. Food and Drug Administration (FDA) back in December 2023.

FDA sees promise in new total artificial heart technology, granting it ‘breakthrough’ status

The device was built as a bridge to transplant for patients with end-stage heart failure. It is made of titanium and approximately the size of an adult’s fist.

Reflow Medical Spur Peripheral Retrievable Stent System

New-look peripheral stent with expandable spikes receives FDA’s de novo classification

California-based Reflow Medical gained the approval after submitting data from the DEEPER REVEAL clinical trial. The device was associated with a high success rate and improved outcomes in CLTI patients.

Mario Gaudino, MD, explains why cardiac surgery trials need more diversity to better inform treatment decisions for women and minorities.

The lack of diversity in cardiac surgery trials may be harmful to patients

Mario Gaudino, MD, PhD, told Cardiovascular Business there is a major need for more women and minorities in today's clinical trials.

Compensation for U.S. cardiologists is up across the board, according to a recent survey published by MedAxiom, an American College of Cardiology company. The report identified similar trends for cardiovascular surgeons, highlighting the country’s high demand for all heart specialists in 2024 and beyond.

SCAI celebrates legacies of pioneer pediatric cardiologists

Five veteran clinicians have been recognized for their lasting impact on the field of pediatric cardiology.